BSX
Price
$68.65
Change
+$0.70 (+1.03%)
Updated
Mar 27, 6:59 PM EST
27 days until earnings call
ISRG
Price
$400.10
Change
+$2.47 (+0.62%)
Updated
Mar 27, 6:59 PM EST
21 days until earnings call
Ad is loading...

Analysis and predictions BSX vs ISRG

Header iconBSX vs ISRG Comparison
Open Charts BSX vs ISRGBanner chart's image
Boston Scientific
Price$68.65
Change+$0.70 (+1.03%)
Volume$1.2M
CapitalizationN/A
Intuitive Surgical
Price$400.10
Change+$2.47 (+0.62%)
Volume$537.51K
CapitalizationN/A
View a ticker or compare two or three
BSX vs ISRG Comparison Chart

Loading...

BSXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ISRGDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BSX vs. ISRG commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a Hold and ISRG is a Hold.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (BSX: $68.62 vs. ISRG: $400.24)
Brand notoriety: BSX and ISRG are both notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BSX: 63% vs. ISRG: 73%
Market capitalization -- BSX: $100.86B vs. ISRG: $141.86B
BSX [@Medical Specialties] is valued at $100.86B. ISRG’s [@Medical Specialties] market capitalization is $141.86B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSX’s FA Score shows that 2 FA rating(s) are green whileISRG’s FA Score has 2 green FA rating(s).

  • BSX’s FA Score: 2 green, 3 red.
  • ISRG’s FA Score: 2 green, 3 red.
According to our system of comparison, ISRG is a better buy in the long-term than BSX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSX’s TA Score shows that 3 TA indicator(s) are bullish while ISRG’s TA Score has 4 bullish TA indicator(s).

  • BSX’s TA Score: 3 bullish, 3 bearish.
  • ISRG’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both BSX and ISRG are a good buy in the short-term.

Price Growth

BSX (@Medical Specialties) experienced а +1.75% price change this week, while ISRG (@Medical Specialties) price change was +2.53% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.04%. For the same industry, the average monthly price growth was -0.16%, and the average quarterly price growth was +4.56%.

Reported Earning Dates

BSX is expected to report earnings on Apr 24, 2024.

ISRG is expected to report earnings on Apr 18, 2024.

Industries' Descriptions

@Medical Specialties (+1.04% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for BSX with price predictions.
OPEN
A.I.dvisor published
a Summary for ISRG with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ISRG($142B) has a higher market cap than BSX($101B). ISRG has higher P/E ratio than BSX: ISRG (79.57) vs BSX (64.13). BSX (18.699) and ISRG (18.635) have similar YTD gains . BSX has higher annual earnings (EBITDA): 3.45B vs. ISRG (2.19B). ISRG has more cash in the bank: 5.22B vs. BSX (865M). BSX has higher revenues than ISRG: BSX (14.2B) vs ISRG (7.12B).
BSXISRGBSX / ISRG
Capitalization101B142B71%
EBITDA3.45B2.19B157%
Gain YTD18.69918.635100%
P/E Ratio64.1379.5781%
Revenue14.2B7.12B199%
Total Cash865M5.22B17%
Total Debt9.49BN/A-
FUNDAMENTALS RATINGS
BSX vs ISRG: Fundamental Ratings
BSX
ISRG
OUTLOOK RATING
1..100
7174
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
90
Overvalued
PROFIT vs RISK RATING
1..100
1924
SMR RATING
1..100
7659
PRICE GROWTH RATING
1..100
1712
P/E GROWTH RATING
1..100
8847
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BSX's Valuation (81) in the Medical Specialties industry is in the same range as ISRG (90). This means that BSX’s stock grew similarly to ISRG’s over the last 12 months.

BSX's Profit vs Risk Rating (19) in the Medical Specialties industry is in the same range as ISRG (24). This means that BSX’s stock grew similarly to ISRG’s over the last 12 months.

ISRG's SMR Rating (59) in the Medical Specialties industry is in the same range as BSX (76). This means that ISRG’s stock grew similarly to BSX’s over the last 12 months.

ISRG's Price Growth Rating (12) in the Medical Specialties industry is in the same range as BSX (17). This means that ISRG’s stock grew similarly to BSX’s over the last 12 months.

ISRG's P/E Growth Rating (47) in the Medical Specialties industry is somewhat better than the same rating for BSX (88). This means that ISRG’s stock grew somewhat faster than BSX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSXISRG
RSI
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
57%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
51%
Bearish Trend 2 days ago
55%
Momentum
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
70%
Declines
ODDS (%)
Bearish Trend 18 days ago
49%
Bearish Trend 9 days ago
60%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
46%
Aroon
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
63%
View a ticker or compare two or three
Ad is loading...
BSXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ISRGDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATOS1.830.03
+1.67%
Atossa Therapeutics
PCH46.950.65
+1.40%
PotlatchDeltic Corp
RMD196.332.15
+1.11%
ResMed
SLCA12.26N/A
N/A
US Silica Holdings
DALN3.79-0.06
-1.56%
DallasNews Corp

BSX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been closely correlated with SYK. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSX jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
+1.00%
SYK - BSX
67%
Closely correlated
+2.61%
RVTY - BSX
52%
Loosely correlated
+1.92%
ISRG - BSX
51%
Loosely correlated
+0.66%
ZBH - BSX
51%
Loosely correlated
+3.90%
ABT - BSX
45%
Loosely correlated
+1.78%
More

ISRG and

Correlation & Price change

A.I.dvisor indicates that over the last year, ISRG has been loosely correlated with RVTY. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ISRG jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ISRG
1D Price
Change %
ISRG100%
+0.66%
RVTY - ISRG
61%
Loosely correlated
+1.92%
SYK - ISRG
56%
Loosely correlated
+2.61%
BSX - ISRG
51%
Loosely correlated
+1.00%
COO - ISRG
50%
Loosely correlated
+1.15%
ABT - ISRG
48%
Loosely correlated
+1.78%
More